Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in Severe Alzheimer s Disease Accepted for Presentation at 11th International Brain Research Organization World Congress of Neuroscience kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics.
A minimally invasive skin test, which measures factors related to brain connections, shows high specificity and sensitivity in new research, with diagnoses of Alzheimer disease confirmed at autopsy.
Synaptogenix (SNPX) Announces Changes to Scientific Advisory Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.